231 related articles for article (PubMed ID: 23648086)
1. Translational approach to develop novel medications on alcohol addiction: focus on neuropeptides.
Ubaldi M; Bifone A; Ciccocioppo R
Curr Opin Neurobiol; 2013 Aug; 23(4):684-91. PubMed ID: 23648086
[TBL] [Abstract][Full Text] [Related]
2. Stress-related neuropeptides and alcoholism: CRH, NPY, and beyond.
Ciccocioppo R; Gehlert DR; Ryabinin A; Kaur S; Cippitelli A; Thorsell A; Lê AD; Hipskind PA; Hamdouchi C; Lu J; Hembre EJ; Cramer J; Song M; McKinzie D; Morin M; Economidou D; Stopponi S; Cannella N; Braconi S; Kallupi M; de Guglielmo G; Massi M; George DT; Gilman J; Hersh J; Tauscher JT; Hunt SP; Hommer D; Heilig M
Alcohol; 2009 Nov; 43(7):491-8. PubMed ID: 19913192
[TBL] [Abstract][Full Text] [Related]
3. Molecular targets of alcohol action: Translational research for pharmacotherapy development and screening.
Gorini G; Bell RL; Mayfield RD
Prog Mol Biol Transl Sci; 2011; 98():293-347. PubMed ID: 21199775
[TBL] [Abstract][Full Text] [Related]
4. A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.
Bell RL; Hauser S; Rodd ZA; Liang T; Sari Y; McClintick J; Rahman S; Engleman EA
Int Rev Neurobiol; 2016; 126():179-261. PubMed ID: 27055615
[TBL] [Abstract][Full Text] [Related]
5. A translational approach to novel medication development for protracted abstinence.
Mason BJ; Higley AE
Curr Top Behav Neurosci; 2013; 13():647-70. PubMed ID: 22351425
[TBL] [Abstract][Full Text] [Related]
6. Emerging targets for addiction neuropharmacology: From mechanisms to therapeutics.
Ubaldi M; Cannella N; Ciccocioppo R
Prog Brain Res; 2016; 224():251-84. PubMed ID: 26822362
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptides and Addiction: An Introduction.
Thiele TE
Int Rev Neurobiol; 2017; 136():1-3. PubMed ID: 29056148
[TBL] [Abstract][Full Text] [Related]
8. Translational studies of alcoholism: bridging the gap.
Zahr NM; Sullivan EV
Alcohol Res Health; 2008; 31(3):215-30. PubMed ID: 20041042
[TBL] [Abstract][Full Text] [Related]
9. The Need for Treatment Responsive Translational Biomarkers in Alcoholism Research.
Heilig M; Sommer WH; Spanagel R
Curr Top Behav Neurosci; 2016; 28():151-71. PubMed ID: 27240677
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapies for alcoholism: the old and the new.
Olive MF
CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):2-4. PubMed ID: 20232494
[TBL] [Abstract][Full Text] [Related]
11. Stress-related neuropeptide systems as targets for treatment of alcohol addiction: A clinical perspective.
Heilig M
J Intern Med; 2023 May; 293(5):559-573. PubMed ID: 37052145
[TBL] [Abstract][Full Text] [Related]
12. NEUROBIOLOGICAL BASES OF ALCOHOL ADDICTION.
Matošić A; Marušić S; Vidrih B; Kovak-Mufić A; Cicin-Šain L
Acta Clin Croat; 2016 Mar; 55(1):134-50. PubMed ID: 27333729
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms.
Heilig M; Egli M
Pharmacol Ther; 2006 Sep; 111(3):855-76. PubMed ID: 16545872
[TBL] [Abstract][Full Text] [Related]
14. Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin.
Martin-Fardon R; Zorrilla EP; Ciccocioppo R; Weiss F
Brain Res; 2010 Feb; 1314():145-61. PubMed ID: 20026088
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic mechanisms of alcoholism and stress-related disorders.
Palmisano M; Pandey SC
Alcohol; 2017 May; 60():7-18. PubMed ID: 28477725
[TBL] [Abstract][Full Text] [Related]
16. Personalized Medicine of Alcohol Addiction: Pharmacogenomics and Beyond.
Ragia G; Manolopoulos VG
Curr Pharm Biotechnol; 2017; 18(3):221-230. PubMed ID: 28240173
[TBL] [Abstract][Full Text] [Related]
17. Who is at risk? Population characterization of alcohol self-administration in nonhuman primates helps identify pathways to dependence.
Grant KA; Stafford J; Thiede A; Kiley C; Odagiri M; Ferguson B
Alcohol Res Health; 2008; 31(4):289-97. PubMed ID: 23584006
[TBL] [Abstract][Full Text] [Related]
18. Prairie Voles as a Model to Screen Medications for the Treatment of Alcoholism and Addictions.
Ryabinin AE; Hostetler CM
Int Rev Neurobiol; 2016; 126():403-21. PubMed ID: 27055620
[TBL] [Abstract][Full Text] [Related]
19. Novel medication targets for the treatment of alcoholism: preclinical studies.
Rezvani AH; Lawrence AJ; Arolfo MP; Levin ED; Overstreet DH
Recent Pat CNS Drug Discov; 2012 Aug; 7(2):151-62. PubMed ID: 22574676
[TBL] [Abstract][Full Text] [Related]
20. Investigational drugs for alcohol use disorders: a review of preclinical data.
Ch'Ng SS; Lawrence AJ
Expert Opin Investig Drugs; 2018 May; 27(5):459-474. PubMed ID: 29723484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
